• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌,大体检查与处理问题:国际妇科病理学家协会的建议

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

作者信息

Malpica Anais, Euscher Elizabeth D, Hecht Jonathan L, Ali-Fehmi Rouba, Quick Charles M, Singh Naveena, Horn Lars-Christian, Alvarado-Cabrero Isabel, Matias-Guiu Xavier, Hirschowitz Lynn, Duggan Máire, Ordi Jaume, Parkash Vinita, Mikami Yoshiki, Ruhul Quddus M, Zaino Richard, Staebler Annette, Zaloudek Charles, McCluggage W Glenn, Oliva Esther

机构信息

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.M., E.D.E.) Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (J.L.H.) Department of Pathology, Massachusetts General Hospital and Harvard Medical School (E.O.), Boston, Massachusetts Department of Pathology, Wayne State University, Detroit, Michigan (R.A.F.) Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (C.M.Q.) Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Cellular Pathology, Birmingham Women's NHS Trust, Birmingham (L.H.), UK Division of Gynecologic, Breast and Perinatal Pathology, University Hospital, Leipzig (L.C.H.) Institute of Pathology, University Hospital of Tübingen, Tübingen (A.S.), Germany Department of Pathology, Hospital de Oncología Siglo XXI, Mexico City, Mexico City, Mexico (I.A.C.) Department of Pathology, Hospital Universitari de Bellvitge and Hospital Universitari de Arnau de Vilanova, Idibell, Irblleida, and Universitat de Lleida, Ciberonc (X.M.G.) Department of Pathology, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona (J.O.), Spain Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada (M.D.) Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (V.P.) Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan (Y.M.) Department of Pathology, Women and Infants Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.R.Q.) Division of Anatomic Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania (R.Z.) Department of Pathology, University of California, San Francisco, San Francisco, California (C.Z.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.).

出版信息

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S9-S24. doi: 10.1097/PGP.0000000000000552.

DOI:
10.1097/PGP.0000000000000552
PMID:30550481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6296844/
Abstract

Endometrial cancer is the most common gynecologic neoplasm in developed countries; however, updated universal guidelines are currently not available to handle specimens obtained during the surgical treatment of patients affected by this disease. This article presents recommendations on how to gross and submit sections for microscopic examination of hysterectomy specimens and other tissues removed during the surgical management of endometrial cancer such as salpingo-oophorectomy, omentectomy, and lymph node dissection-including sentinel lymph nodes. In addition, the intraoperative assessment of some of these specimens is addressed. These recommendations are based on a review of the literature, grossing manuals from various institutions, and a collaborative effort by a subgroup of the Endometrial Cancer Task Force of the International Society of Gynecological Pathologists. The aim of these recommendations is to standardize the processing of endometrial cancer specimens which is vital for adequate pathological reporting and will ultimately improve our understanding of this disease.

摘要

子宫内膜癌是发达国家最常见的妇科肿瘤;然而,目前尚无最新的通用指南来处理该疾病患者手术治疗期间获取的标本。本文就如何大体检查和提交子宫切除术标本以及子宫内膜癌手术管理过程中切除的其他组织(如输卵管卵巢切除术、网膜切除术和淋巴结清扫术——包括前哨淋巴结)的切片进行显微镜检查提出建议。此外,还讨论了其中一些标本的术中评估。这些建议基于文献综述、各机构的大体检查手册以及国际妇科病理学家协会子宫内膜癌特别工作组一个小组的合作努力。这些建议的目的是规范子宫内膜癌标本的处理,这对于充分的病理报告至关重要,并最终将增进我们对这种疾病的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/1c54b52c2f9c/pgp-38-s009-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/c65d2c1a12b3/pgp-38-s009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/c31cc47e3b01/pgp-38-s009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/4327e07ed8b1/pgp-38-s009-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/a2422ad4120f/pgp-38-s009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/76bd5f2a096b/pgp-38-s009-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/4a510dfc3591/pgp-38-s009-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/8f4139a3704c/pgp-38-s009-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/6c037b88b301/pgp-38-s009-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/1c54b52c2f9c/pgp-38-s009-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/c65d2c1a12b3/pgp-38-s009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/c31cc47e3b01/pgp-38-s009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/4327e07ed8b1/pgp-38-s009-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/a2422ad4120f/pgp-38-s009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/76bd5f2a096b/pgp-38-s009-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/4a510dfc3591/pgp-38-s009-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/8f4139a3704c/pgp-38-s009-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/6c037b88b301/pgp-38-s009-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d36/6296844/1c54b52c2f9c/pgp-38-s009-g009.jpg

相似文献

1
Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.子宫内膜癌,大体检查与处理问题:国际妇科病理学家协会的建议
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S9-S24. doi: 10.1097/PGP.0000000000000552.
2
A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.机器人辅助子宫内膜癌分期时荧光成像探测前哨淋巴结的前瞻性研究。
Am J Obstet Gynecol. 2016 Jul;215(1):117.e1-7. doi: 10.1016/j.ajog.2015.12.046. Epub 2015 Dec 29.
3
Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists.宫颈腺癌,大体检查和处理,包括术中评估:国际妇科病理学家学会的建议。
Int J Gynecol Pathol. 2021 Mar 1;40(Suppl 1):S24-S47. doi: 10.1097/PGP.0000000000000745.
4
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.子宫内膜癌前哨淋巴结图谱绘制与分期:妇科肿瘤学会文献综述及共识推荐
Gynecol Oncol. 2017 Aug;146(2):405-415. doi: 10.1016/j.ygyno.2017.05.027. Epub 2017 May 28.
5
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.子宫内膜癌诊断:国际妇产科病理学家学会关于在临床实践中使用国际妇产科联盟(FIGO)分级和基因组亚类的建议
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S64-S74. doi: 10.1097/PGP.0000000000000518.
6
Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.子宫内膜癌前哨淋巴结 mapping:最新进展。 (注:这里“mapping”直译为“映射”,结合医学语境,推测是一种关于前哨淋巴结的定位或标记等相关技术,可根据实际情况进一步优化表述,但按要求不添加解释说明,所以保留原文形式。)
Oncologist. 2016 Apr;21(4):461-6. doi: 10.1634/theoncologist.2015-0473. Epub 2016 Mar 9.
7
Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.早期子宫内膜癌前哨淋巴结检测的价值及最佳方法:选择性淋巴结清扫算法
Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:35-39. doi: 10.1016/j.ejogrb.2018.03.042. Epub 2018 Mar 23.
8
Endometrial Carcinoma: Grossing, Frozen Section Evaluation, Staging, and Sentinel Lymph Node Evaluation.子宫内膜癌:大体检查、冰冻切片评估、分期及前哨淋巴结评估
Surg Pathol Clin. 2019 Jun;12(2):329-342. doi: 10.1016/j.path.2019.02.002.
9
Pathological processing of sentinel lymph nodes in endometrial carcinoma - routine aspects of grossing, ultra-staging, and surgico-pathological parameters in a series of 833 lymph nodes.子宫内膜癌前哨淋巴结的病理处理——833 个淋巴结系列中大体检查、超分期和手术病理参数的常规方面。
Virchows Arch. 2022 Sep;481(3):421-432. doi: 10.1007/s00428-022-03377-6. Epub 2022 Jul 19.
10
Practical Updates and Diagnostic Challenges in Endometrial Carcinoma.子宫内膜癌的实用更新和诊断挑战。
Arch Pathol Lab Med. 2024 Jan 1;148(1):78-98. doi: 10.5858/arpa.2022-0280-RA.

引用本文的文献

1
A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers.香豆素及其相关衍生物作为多靶点治疗药物在妇科癌症治疗中的潜力综述
Front Pharmacol. 2024 Sep 16;15:1423480. doi: 10.3389/fphar.2024.1423480. eCollection 2024.
2
New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.子宫内膜癌的新临床病理概念:组织学特征与分子谱的整合。
Pathol Int. 2024 Oct;74(10):557-573. doi: 10.1111/pin.13471. Epub 2024 Aug 22.
3
[Endometrial carcinoma: molecular classification in routine pathology].

本文引用的文献

1
International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.国际子宫内膜癌发病率的模式和趋势,1978-2013 年。
J Natl Cancer Inst. 2018 Apr 1;110(4):354-361. doi: 10.1093/jnci/djx214.
2
Intraoperative Pathologic Consultation on Hysterectomy Specimens for Endometrial Cancer: An Assessment of the Accuracy of Frozen Sections, "Gross-Only" Evaluations, and Obtaining Random Sections of a Grossly "Normal" Endometrium.子宫内膜癌子宫切除标本的术中病理会诊:对冰冻切片、“仅大体检查”评估以及获取大体“正常”子宫内膜随机切片准确性的评估
Am J Clin Pathol. 2017 Oct 1;148(4):345-353. doi: 10.1093/ajcp/aqx076.
3
[子宫内膜癌:常规病理学中的分子分类]
Pathologie (Heidelb). 2024 Sep;45(5):347-354. doi: 10.1007/s00292-024-01345-2. Epub 2024 Aug 14.
4
Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma.评估和报告子宫内膜癌脉管间隙浸润(LVSI)的实用指南。
Histopathology. 2025 Jan;86(2):173-182. doi: 10.1111/his.15272. Epub 2024 Jun 27.
5
Recent management of endometrial cancer: a narrative review of the literature.子宫内膜癌的近期管理:文献综述
Front Med (Lausanne). 2024 Jan 3;10:1244634. doi: 10.3389/fmed.2023.1244634. eCollection 2023.
6
Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists.子宫内膜癌的分子分类与2023年国际妇产科联盟(FIGO)分期:探讨病理学家面临的挑战与机遇
Cancers (Basel). 2023 Aug 15;15(16):4101. doi: 10.3390/cancers15164101.
7
FIGO staging of endometrial cancer: 2023.国际妇产科联盟(FIGO)子宫内膜癌分期:2023 年。
J Gynecol Oncol. 2023 Sep;34(5):e85. doi: 10.3802/jgo.2023.34.e85. Epub 2023 Aug 8.
8
The Role of FBXW7 in Gynecologic Malignancies.FBXW7 在妇科恶性肿瘤中的作用。
Cells. 2023 May 17;12(10):1415. doi: 10.3390/cells12101415.
9
PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.过氧化物酶体增殖物激活受体 α 激动剂厄贝沙坦通过 SREBP1 和 ARID1A 抑制子宫内膜癌细胞的增殖。
Oncol Res. 2023 May 24;31(3):239-253. doi: 10.32604/or.2023.026067. eCollection 2023.
10
The Risk of Recurrence in Endometrial Cancer Patients with Low-Volume Metastasis in the Sentinel Lymph Nodes: A Retrospective Multi-Institutional Study.前哨淋巴结低容量转移的子宫内膜癌患者的复发风险:一项回顾性多机构研究
Cancers (Basel). 2023 Mar 30;15(7):2052. doi: 10.3390/cancers15072052.
Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods.
根据两种不同方法的使用对子宫内膜癌前哨淋巴结进行超分期
Int J Gynecol Pathol. 2018 May;37(3):242-251. doi: 10.1097/PGP.0000000000000415.
4
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.子宫内膜癌前哨淋巴结图谱绘制与分期:妇科肿瘤学会文献综述及共识推荐
Gynecol Oncol. 2017 Aug;146(2):405-415. doi: 10.1016/j.ygyno.2017.05.027. Epub 2017 May 28.
5
Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.使用旋切器行阴道子宫切除术后隐匿性子宫恶性肿瘤的发生率。
J Minim Invasive Gynecol. 2017 May-Jun;24(4):665-669. doi: 10.1016/j.jmig.2017.01.025. Epub 2017 Feb 24.
6
Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.良性疾病子宫粉碎术时隐匿性癌前或恶性病变的患病率。
Int J Gynaecol Obstet. 2017 May;137(2):123-128. doi: 10.1002/ijgo.12111. Epub 2017 Feb 28.
7
Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions.经典方法与SEE-FIM方案在检测伴有妇科病变的输卵管微观病变中的比较
J Pathol Transl Med. 2018 Jan;52(1):21-27. doi: 10.4132/jptm.2016.06.17. Epub 2016 Aug 19.
8
Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.林奇综合征患者预防性和非预防性子宫切除标本的病理结果
Am J Surg Pathol. 2016 Sep;40(9):1177-91. doi: 10.1097/PAS.0000000000000684.
9
Prevalence of Occult Malignancy Within Morcellated Specimens Removed During Laparoscopic Sacrocolpopexy.腹腔镜骶骨阴道固定术中切除的切碎标本中隐匿性恶性肿瘤的患病率
Female Pelvic Med Reconstr Surg. 2016 Jul-Aug;22(4):190-3. doi: 10.1097/SPV.0000000000000257.
10
Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome.与子宫病理学相关的实际问题:分期、冰冻切片、伪像和林奇综合征。
Mod Pathol. 2016 Jan;29 Suppl 1(Suppl 1):S59-77. doi: 10.1038/modpathol.2015.127.